John Gregson

Jun 2, 2024 | jacc.org | John Gregson |Stuart J. Pocock |Stefan Anker |Deepak L. Bhatt

References1. "The analysis of survival data in nephrology: basic concepts and methods of Cox regression". Kidney Int . 2008;74:705-709. 2. "A proportional hazards model for the subdistribution of a competing risk". J Am Stat Assoc . 1999;94:496-509. 3. "Applying Cox regression to competing risks". Biometrics . 1995;51:524-532. 4. "Relaxing the independent censoring assumption in the Cox proportional hazards model using multiple imputation". Stat Med . 2014;33:4681-4694. 5. "R package InformativeCensoring.

May 3, 2024 | dialnet.unirioja.es | John Gregson |Joao Ferreira |Tim Collier |Joao Pedro

winratiotest: A command for implementing the win ratio and stratified win ratio in StataAutores: John Gregson, João Pedro Ferreira, Tim CollierLocalización: The Stata journal, ISSN 1536-867X, Vol. 23, Nº. 3, 2023, págs. 835-850Idioma: inglésEnlacesTexto completoResumenThe win ratio is a statistical method most commonly used for ana- lyzing composite outcomes in clinical trials.

Aug 11, 2023 | onlinecjc.ca | John Gregson |Stuart J. Pocock

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Jul 2, 2023 | jacc.org | John Gregson |Gregg W. Stone |Deepak L. Bhatt |Milton Packer

1. "Comparison of time-to-first event and recurrent-event methods in randomized clinical trials". Circulation . 2018;138:570-577. 2. "Time to move on from “time-to-first”: Should all events be included in the analysis of clinical trials?"Eur Heart J . 2012;33:2764-2765. 3. "Sotagliflozin in patients with diabetes and chronic kidney disease". N Engl J Med . 2021;384:129-139. 4. "Sotagliflozin in patients with diabetes and recent worsening heart failure". N Engl J Med . 2021;384:117-128. 5.